...
首页> 外文期刊>European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology >Modified CLIP using PIVKA-II for evaluating prognosis after hepatectomy for hepatocellular carcinoma.
【24h】

Modified CLIP using PIVKA-II for evaluating prognosis after hepatectomy for hepatocellular carcinoma.

机译:使用PIVKA-II修改的CLIP用于评估肝细胞癌肝切除术后的预后。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

AIMS: The new staging system proposed by the Cancer of the Liver Italian Program (CLIP) for hepatocellular carcinoma (HCC) accounts for both liver dysfunction and tumour characteristics. The present study was designed to analyze UICC TNM stage, CLIP and modified CLIP in 91 patients who underwent hepatic resection for HCC.METHODS: In the modified CLIP, scoring of AFP was replaced by that of protein induced by vitamin K absence or antagonist II (PIVKA-II; predictive value, >/=400mAU/ml).RESULTS: After hepatic resection, 54 patients developed recurrent tumours. High PIVKA-II was a significant determinant of recurrence (p<0.05). However, a high score of the modified CLIP as well as those other staging systems did not correlate with tumour-recurrence rate. Univariate analysis showed that high TNM score, CLIP score and our modified CLIP score were significant predictors of poor prognosis. Multivariate Cox's analysis revealed that high PIVKA-II and high modified CLIP score were associated with higher risk fordisease-free and overall survival as well as high TNM stage.CONCLUSIONS: Compared with the original CLIP, our modified CLIP was a better predictor of prognosis of HCC patients who underwent hepatic resection.
机译:目的:由意大利肝癌计划(CLIP)提出的针对肝细胞癌(HCC)的新分期系统考虑了肝功能障碍和肿瘤特征。本研究旨在分析91例行肝癌切除术的HCC患者的UICC TNM分期,CLIP和改良的CLIP。 PIVKA-II;预测值,> / = 400mAU / ml)。结果:肝切除后,有54例患者出现了复发性肿瘤。高PIVKA-II是复发的重要决定因素(p <0.05)。但是,改良的CLIP以及其他分期系统的高分与肿瘤复发率无关。单因素分析表明,高TNM评分,CLIP评分和改良后的CLIP评分是不良预后的重要预测指标。多变量Cox的分析显示,较高的PIVKA-II和较高的CLIP评分与较高的无病风险和总体生存率以及较高的TNM分期相关。结论:与原始的CLIP相比,改良的CLIP可以更好地预测预后接受肝切除术的HCC患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号